LIN CHUNG, Director, Global Scientific and Regulatory Documentation, Bristol-Myers Squibb

Lin Chung, PharmD RPh, is a Director in Global Scientific and Regulatory Documentation at Bristol-Myers Squibb (BMS) Company with 15 years of pharmaceutical industry experience. She began her career as a pharmacovigilance aggregate reporting scientist at Janssen Pharmaceutical Companies of Johnson & Johnson. In her current role, Lin serves as the process lead for investigator’s brochures and manages a team of scientific writers authoring investigator’s brochures, safety aggregate reports and risk management documents. She is passionate about patient safety and is dedicated to deliver innovative medicines to patients.